Thomas Tscherning

Thomas Tscherning joined BankInvest Biomedical Venture in 1997 as the first founding member of the venture-dedicated unit, co-raising the first two venture funds of MDKK 355 and 288, respectively. Covering the whole value chain of venture capital, Dr. Tscherning has been reviewer of approximately 2500 incoming projects since the start in 1997, which over the last 12 months - amounts to approximately 1 new globally-derived investment opportunity per day.